•
Sep 30, 2022

REGENXBIO Q3 2022 Earnings Report

Total Revenue
$26.5M
Previous year: $30.8M
-13.8%
EPS
-$1.75
Previous year: -$1.37
+27.7%
Gross Profit
$13.4M
Previous year: $16.7M
-19.5%
Cash and Equivalents
$119M
Previous year: $228M
-48.1%
Free Cash Flow
-$55.5M
Previous year: -$55.1M
+0.8%
Total Assets
$884M
Previous year: $800M
+10.4%

REGENXBIO

REGENXBIO